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ABSTRACT
Kyphosis and scoliosis are common spinal disorders that occur as part of complex syndromes or as nonsyndromic, idiopathic
diseases. Familial and twin studies implicate genetic involvement, although the causative genes for idiopathic kyphoscoliosis
remain to be identified. To facilitate these studies, we investigated progeny of mice treated with the chemical mutagen N-ethyl-
N-nitrosourea (ENU) and assessed them for morphological and radiographic abnormalities. This identified a mouse with
kyphoscoliosis due to fused lumbar vertebrae, which was inherited as an autosomal dominant trait; the phenotype was
designated as hereditary vertebral fusion (HVF) and the locus as Hvf. Micro–computed tomography (mCT) analysis confirmed the
occurrence of nonsyndromic kyphoscoliosis due to fusion of lumbar vertebrae in HVF mice, consistent with a pattern of blocked
vertebrae due to failure of segmentation. mCT scans also showed the lumbar vertebral column of HVF mice to have generalized
disc narrowing, displacement with compression of the neural spine, and distorted transverse processes. Histology of lumbar
vertebrae revealed HVF mice to have irregularly shaped vertebral bodies and displacement of intervertebral discs and
ossification centers. Genetic mapping using a panel of single nucleotide polymorphic (SNP) loci arranged in chromosome sets
and DNA samples from 23 HVF (eight males and 15 females) mice, localized Hvf to chromosome 4A3 and within a 5-megabase
(Mb) region containing nine protein coding genes, two processed transcripts, three microRNAs, five small nuclear RNAs, three
large intergenic noncoding RNAs, and 24 pseudogenes. However, genome sequence analysis in this interval did not identify any
abnormalities in the coding exons, or exon-intron boundaries of any of these genes. Thus, our studies have established a mouse
model for a monogenic form of nonsyndromic kyphoscoliosis due to fusion of lumbar vertebrae, and further identification of the
underlying genetic defect will help elucidate the molecular mechanisms involved in kyphoscoliosis. © 2018 The Authors. JBMR
Plus is published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.
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Introduction
Kyphosis is a common disorder of the vertebral column
(1) that
can occur in isolation, or in association with scoliosis in
infants(2) and adolescents,(3) and osteoporosis in the elderly,(1)
causing pain, decreased function and activity,(1) and increased risk
ofmortality inolderwomenabove the ageof 65 years.(1,4)Kyphosis,
scoliosis, or kyphoscoliosis, canoccur at anyage, secondary toother
underlying developmental, musculoskeletal, neuromuscular, or
spinal disorders,(5–10) andmaybepart of complex disorders such as
the CHARGE syndrome (coloboma of the eye, heart defects, atresia
of the nasal choanae, retardation of growth and/or development,
genital and/or urinary abnormalities, and ear abnormalities and
deafness),(9,11) or occur as a nonsyndromic condition. Indeed, the
most common forms of kyphosis and scoliosis in adolescents are
nonsyndromic and include: Scheuermann disease(3) a form of
nonsyndromic kyphosis, which affects >8% of the population(12);
idiopathic scoliosis (IS), which affects approximately 2% to 3%
individuals(13–16); and congenital nonsyndromic scoliosis, which is
reported to have a prevalence of approximately 0.5 to 1 per 1000
individuals.(9) Familial and twin studies have indicated a genetic
basis for kyphosis(17–20) and scoliosis,(21–28) with likely genetic
heterogeneity. However, studies aimed at defining the genetic
abnormalities causing these spinal disorders have been hampered
by their phenotypic and genetic heterogeneity, variable modes of
inheritance,(8,29) and gene-environment interactions that may
modify the phenotypic expression.(9) To facilitate these studies, we
investigated the progeny of mice treated with the chemical
mutagen N-ethyl-N-nitrosourea (ENU),(30) which is an alkylating
agent that inducesmutations inDNAata frequencyof1 inevery1.5
megabases (Mb).(31) These mutations consist mainly of SNPs, and
occasionally small indels, butnot large structural variants.(31)Similar
approaches using phenotypic assessments of mice with ENU
mutations has successfully identified mouse models for hereditary
human disorders, including skeletal dysplasias.(32–34) Here, we
report an ENU mouse mutant with kyphoscoliosis due to lumbar
vertebral fusion.
Materials and Methods
Ethics statement
All animal studies were carried out using guidelines issued by
theMedical Research Council (MRC) (UK) in “Responsibility in the
Use of Animals for Medical Research” (July 1993) and Home
Office Project License Number 30/2433. Experiments were also
approved by the MRC Harwell ethics committee.
Generation of mutant mice
Male C57BL/6J mice were treated with ENU and mated with
untreated C3H/HeH female mice,(31) and the resulting progeny
were screened at 12 weeks of age for autosomal dominant
phenotypes.(34) In vitro fertilization was used to generate
progeny, using methods previously described.(35) Mice were
fed an expanded rat and mouse no. 3 breeding diet (Special
Diets Services, Witham, UK) containing 1.15% calcium, 0.82%
phosphate, and 4088.65 units/kg vitamin D, and given water ad
libitum.
Phenotype assessment, radiography, and DXA
Mice were assessed for dysmorphology as described (European
Mouse Phenotyping Resource of Standardised Screens
[EMPReSS]).(36) Anaesthetized mice were assessed by digital
radiography at 26 kV for 3 s using a Faxitron MX-20 digital X-ray
system (Faxitron X-ray Corporation, Lincolnshire, IL, USA)(34) and
DXA using a Lunar PIXImus densitometer (GE Healthcare, Chalfont
St Giles, UK), as reported.(37)X-ray imageswere processedusing the
DicomWorks software (http://www.dicomworks.com/) and DXA
images were processed using the PIXImus software.(37)
Micro–computed tomography analysis
Formalin-fixed skeletons and dissected bones were examined
using a micro–computed tomography (mCT) scanner (model
1172a; Skyscan/Bruker, Kontich, Belgium) at 50 kV and 200mA
utilizing a 0.5-mm aluminum filter and a detection pixel size of
4.3mm2 (tibias and lumbar vertebrae) and 17.4mm2 (spinal
columns and rib cages). For each specimen, images were
captured every 0.7 degrees through a 360-degree rotation. The
lumbar vertebrae were scanned separately to measure trabecu-
lar bone,(38) using a detection pixel size of 4.3mm2, and images
were scanned every 0.7 degrees through a 180-degree
rotation.(34) Scanned images were reconstructed using Skyscan
NRecon software and analyzed using the Skyscan CT analysis
software (CT Analyser v1.8.1.4; Skycan).(34) Total bone volume
(mm3) and bone mineral density (g/cm3) were measured over
the entire volume of the bone (CT Analyser v1.8.1.4; Skycan).
Trabecular bone volume as proportion of tissue volume (BV/TV,
%), trabecular thickness (Tb.Th, mm 10 2), trabecular number
(Tb. N, mm 1), and structure model index (SMI) were assessed
for the first and second lumbar vertebrae, using the CT analysis
software.(34) Intact vertebral columns were modeled using
Skyscan CT volume software and images captured (CT Vol:
Realistic 3D-Visualization v1.11.0.2; Skyscan). Cross-sections of
lumbar vertebrae and tibias were generated using Skyscan CT
analysis software.
Histology
Dissected vertebrae were fixed in 10% formalin, decalcified in
formical-4 (Decal Chemical Corporation, Suffern, NY, USA) for
3 days before embedding in paraffinwax.(34) Sections (3 to 4mm)
were cut using a Leica Microsystems Microtome (Leica Micro-
systems, Milton Keynes, UK) and stained with hematoxylin and
eosin (H&E). Slides were examined using a Leica microscope
model DM4000B (Leica Microsystems) and images captured
using a QImaging camera model 10-RET-OEM-F-CLR-12 (QImag-
ing, Surrey, BC, Canada).(34)
Plasma biochemistry
Blood samples were collected from the lateral tail vein of mice
that had fasted for 4 hours. Plasma samples were analyzed, using
a Beckman Coulter AU680 semi-automated clinical chemistry
analyzer (Beckman Coulter, HighWycombe, UK), for total calcium,
phosphate, and albumin concentrations, and alkaline phospha-
tase activity, as described.(39) Plasma calcium was adjusted for
variations in albumin concentrations using the formula:
((albumin-mean albumin) 0.02)þ calcium), as described.(39)
Statistical analysis
Statistical analysis was performed using Microsoft Excel 2010
(Microsoft Corp., Redmond, WA, USA) and GraphPad Prism
(GraphPad Software, Inc., La Jolla, CA, USA). Significance of
differences was assessed by unpaired two-tailed Student’s t test,
or Fisher’s exact test(37); p< 0.05 was considered significant.
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Mapping studies, genome sequencing, Sanger DNA
sequence analysis and amplification-refractory mutation
system–PCR
Genomic DNA was extracted from ear or tail biopsies as
described.(34) and amplified by PCR for genomewide mapping
using a panel of 91 SNP loci arranged in chromosome sets, and
the products were analyzed by pyrosequencing.(40) Whole-
genome sequencing was undertaken using DNA from one
affected HVF mouse and the two parental strains (C57BL/6J and
C3H/HeH), to generate a library, and 100-nucleotide (nt) paired-
end sequencing generated using an Illumina HiSeq 2000
sequencer as described.(35) Sequencing data was analyzed
using a previously described pipeline.(35) Briefly, sequences were
aligned to the mouse reference genome NCBIM38/mm10 using
the Burrows-Wheeler Aligner. SNPs and small indels were
detected using the Genome Analysis Toolkit (GATK) unified
GenotypeCaller(41) with dbSNP version 137 as the background
SNP set and default parameters. Only SNPswithmapping quality
>100 and read depth >3 (“high confidence SNPs”) were
considered further, and these were functionally annotated using
next-generation sequencing (NGS)-SNP.(35) High-confidence
SNPs were filtered against a precompiled list found in 17 inbred
strains from the Mouse Genome Project(42) and from the two
parental strains. DNA sequence analysis was undertaken by PCR
amplification using gene-specific primers for individual exons
and adjacent splice sites and Taq PCR Mastermix (Qiagen,
Crawley, UK), and the DNA sequence of the PCR products
determined using BigDye terminator reagents and an ABI 3100
sequencer (Life Technologies, Carlsbad, CA, USA).(34) Amplifica-
tion-refractorymutation system (ARMS)-PCR was undertaken for
further studies of a variant inMap3k7 in 24mice, as described.(43)
Results
Identification of HVF mice and inheritance as an
autosomal dominant trait
Radiography analysis of 12-week-old progeny derived bymating
of an ENU-mutagenized male C57BL/6J mouse with a wild-type
(WT) C3H/HeH female mouse identified a female mutant with
fused lumbar vertebrae (L2 and L3) and kyphosis (Fig. 1A).
Normal mating of this affected female mouse with WT C3H/HeH
male mice was repeatedly unsuccessful, because the back
deformities, due to the kyphoscoliosis, hindered mounting. In
vitro fertilization, utilizing sperm from a WT C3H/HeH male
mouse, was therefore used to generate progeny for inheritance
testing, and radiography analysis of the 52 (25 male and 27
female) progeny at 12 weeks revealed that 23 (eight males and
15 females) (ie, 44%) were affected with fusion of two to four
lumbar vertebrae, consistent with an autosomal dominant
inheritance. The phenotype was designated as hereditary
vertebral fusion (HVF), and the locus as Hvf. HVF was associated
with kyphosis in 30% of affected mice, scoliosis in 17%, and
kyphoscoliosis in 30% of mice (Fig. 1B, C). The affected mice did
not have dysmorphology or other radiological abnormalities
and were therefore representative of nonsyndromic kyphosco-
liosis. In addition, inspection of these mice did not detect any
gross morphological abnormalities at earlier ages.mCT scanning
analysis confirmed the occurrence of the spinal abnormalities of
kyphosis (Fig. 2A) and scoliosis (Fig. 2B) associated with fusion of
the lumbar vertebrae (Fig. 2C), which was consistent with a
pattern of blocked vertebrae due to failure of segmentation.
Histology of the lumbar vertebrae revealed irregularly shaped
vertebral bodies and displacement of intervertebral discs and
ossification centers in HVFmice (Fig. 2D). The severity of the HVF
phenotype was similar in males and females and the proportion
of males that were affected (32%) and females that were
affected (56%) did not differ significantly (Fisher’s exact test,
p¼ 0.103), consistent with the autosomal dominant inheritance
of HVF. Analysis of plasma calcium, phosphate, and albumin
concentrations and alkaline phosphatase activity did not reveal
any differences between HVF mice and unaffected littermates
(data not shown).
Phenotypic assessment of HVF mice
Further phenotype analysis using DXA and mCT analysis was
undertaken. DXA was performed on 30 mice, which consisted of
20 WT littermates (13 males and seven females) and 10 HVF mice
(threemales and seven females), aged12weeks. Bodyweightwas
significantly reduced by>25% in theHVFmice (mean SD ofWT
versus HVF females¼ 28.66 1.58 g versus 21.03 0.78 g,
p< 0.001; and WT males¼ 35.02 2.43 g, with each of the three
HVF male mice being  5 SD below the WT mean, and this was
associated with a >20% decrease in lean mass (WT versus HVF
females¼ 20.62 1.68 g versus 16.15 0.78 g, p< 0.001; andWT
males¼ 27.14 1.87 g with each of the three HVF male mice
being 4 to 5 SD below theWTmean) and a>40% decrease in
fat mass (WT versus HVF females¼ 6.27 1.18 g versus
3.66 0.46 g, p< 0.001; and WT males¼ 7.9 2.7 g with each
of the three HVF male mice being  1 to  2 SD below the WT
mean). Whole-body bone mineral density (BMD) was similar in
female HVF mice compared to WT mice (WT versus HVF¼ 61.1
 2.4mg/cm2 versus 58.4 2.3 g/cm2) and 8% lower in male
HVF compared to WT (WT versus HVF¼ 61.0 0.9 g/cm2 with
eachof the threeHVFmalemice being 3 to 6 SDbelow theWT
mean). mCT analysis was undertaken on the lumbar vertebrae
from 11 mice, which comprised five WT females and six HVF
females (Fig. 3). Cross-sectional analysis of the vertebral column
from WT and HVF mice (Fig. 3A) revealed HVF mice to have
generalized disc narrowing, fusion of lumbar vertebrae, and
displacement with compression of the neural spine adjacent to
regions with dorsal disc narrowing. Cross-sectional analysis of
individual lumbar vertebrae revealed the HVF mutant to have
distorted transverse processes, and wider neural spine and bone
formation in the spaces between L3, L4, and L5 (Fig. 3B). In
addition, L3 to L5 from the HVF mutant had distorted neural
canals, and the lower ends of L2 to L5had an abnormal orientation
due to scoliosis in this region (Fig. 3B). Additional quantitative
cross-sectional analysis of the first and second lumbar vertebrae
(Fig. 3B) fromWT (n¼ 13males and n¼ 13 females) andHVFmice
(n¼ 5 males and n¼ 9 females) revealed no significant differ-
ences in trabecular bone volume, trabecular thickness, or bone
density. X-ray, DXA, and mCT analyses did not reveal any other
bone phenotypes apart from the vertebrae.
Mapping of the Hvf locus to chromosome 4A3 and
genome sequencing
Genomewide mapping studies using 97 SNPs and DNA samples
from 23 HVF (15 females and eightmales) affectedmicemapped
the Hvf locus to chromosome 4. HVF was found to cosegregate
with C57BL/6 alleles identified by nine SNPs from chromosome 4
(Fig. 4) (LOD score > þ6.5), and no other locus was found to
segregate with the HVF phenotype. An examination of the
haplotypes helped to further localize the Hvf locus; 16 HVF mice
had inherited non-recombinant chromosome 4 haplotypes,
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whereas seven HVFmice had inherited recombinant haplotypes.
The recombinant haplotypes in three HVFmice helped to define
the critical 5-Mb interval (Fig. 4); because two HVF mice had
recombinants between the disease locus (Hvf) and the
centromeric SNPs, including rs4138316, and another mouse
had a recombination between Hvf and the telomeric loci,
including themicrosatellite locus atmapposition 28.2Mb. These
results locate Hvf to a 5-Mb interval flanked centromerically by
rs4138316 and telomerically by the microsatellite locus at the
28.2-Mb position. This interval could not be refined further
because strain-specific polymorphic loci within this region are
not available. This interval contains 46 genes or likely expressed
transcripts which include: the nine known protein coding genes
(kelch-like 32 [Klhl32], NADH dehydrogenase-ubiquinone-1-
alpha subcomplex assembly factor 4 [Ndufaf4], G protein-
coupled receptor 63 [Gpr63], four and a half LIM domains 5
[Fhl5], fucosyltransferase 9 [Fut9], mannosidase endo-alpha
[Manea], betaine-homocysteine methyltransferase pseudo-
gene-1-pseudogene [Bhmt-ps1], MMS22-like DNA repair protein
[Mms22L], and RIKEN cDNA 1810074P20 gene [1810074P20Rik])
(Fig. 4); two processed transcripts; three microRNAs; five small
nuclear RNAs; three large intergenic noncoding RNAs; and 24
pseudogenes (Supporting Table 1). An analysis of these genes
and likely expressed transcripts did not reveal any links with the
molecular pathways that are known to cause kyphosis or
patterning defects, such as the Notch pathway, andwe therefore
carried out whole-genome sequencing. Approximately 95% of
the 5-Mb candidate interval was covered by sequencing data,
with an average depth of 11. This did not identify any
nucleotide variants within the coding regions and splice
junctions any of the nine coding genes, the two processed
transcripts, threemicroRNAs, five small nuclear RNAs, three large
intergenic noncoding RNAs, or 24 pseudogenes within the 5-Mb
candidate interval, or up to 2Mb telomeric or centromeric to the
candidate interval. This was confirmed by Sanger DNA sequence
analysis of the coding regions, splice junctions and 50
untranslated regions of the nine known coding genes, and of
the five small nuclear RNAs, which did not reveal any
abnormalities. Six intergenic and three intronic SNPs were
present within the candidate region; however, none of these
SNPs were found to be within conserved sequences between
human, rat, and chimp genomes (Vista Genome Browser; http://
pipeline.lbl.gov/cgi-bin/gateway2), or within any regulatory
regions in ENCODE (https://www.encodeproject.org/). Genome
sequencing identified a novel, high-confidence coding variant in
the mitogen-activated protein kinase kinase kinase 7 (Map3k7)
gene, which was located 3.8 Mb telomerically of the critical
interval. This variant, which was a C>A transversion at c.702 of
Map3k7 that predicted the missense mutation Ala179Asp, was
studied, using ARMS-PCR, for cosegregation with the HVF
phenotype in 24 mice (nine HVF and 15 unaffected littermates).
This Map3k7 variant did not cosegregate with the HVF
phenotype, because five of 15 unaffected mice were found to
harbor the variant and one of nine affected HVF mice did not
harbor the variant (data not shown), consistent with thisMap3k7
variant being located outside the critical interval. Thus, the
causative mutation for HVF is likely to involve the regulatory
region of one the 46 genes within the critical interval, or possibly
a regulatory region that acts over a longer range to alter the
expression of a gene outside the critical interval.
Discussion
Our study has established an ENU-induced mutant mouse
model, HVF, for an autosomal dominant form of nonsyndromic
Fig. 1. Radiographic analysis of WT littermates and HVF female mice at 12 weeks. Plain radiographs showing (A) kyphosis and (B) scoliosis in HVF mice.
(C) Radiographs of dissected vertebrae from WT littermate and HVF mice showing scoliosis and fusion of lumbar vertebrae (L3 to L6) in HVF mice.
WT¼wild-type.
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kyphoscoliosis that is associated with fusion of lumbar
vertebrae, and reductions in lean mass and fat mass, and this
has some similarities to a form of human congenital scoliosis
referred to as block vertebrae.(9) Congenital scoliosis in man can
be classified into two main patterns of presentation, namely: (i)
failure of formation due to the presence of hemivertebrae and
wedged vertebrae; and (ii) failure of segmentation which
consists of unilateral unsegmented bars with and without
hemivertebrae, and bilateral failure of segmentation (block
vertebrae).(9) The HVF mouse model resembles the failure of
segmentation (block vertebrae) pattern (Figs. 1 and 2; Table 1)
which has been reported in3% of 251 patients with congenital
scoliosis,(44) and to have a prevalence of approximately 0.5 to 1
per 1000 individuals.(9) Thus, identifying the genetic defect
causing HVF may help to identify a component in the complex
pathways regulating vertebral formation, which is likely to
involve the expression of multiple genes. Indeed, studies of
other mouse mutants presenting with abnormalities in the axial
skeleton including tail kinks, kyphosis, and scoliosis have
revealed multiple conserved chromosomal loci harboring genes
that are likely to be candidates for human kyphosis and
scoliosis(8,45); however, it is clear from their polygenic nature that
no single mouse mutant identified thus far can serve as a
complete model for investigating these disorders.
The phenotype of HVF mice also has some similarities to two
other rodent models; these are the Ishibashi rat (ISR) model
which arose spontaneously during inbreeding of agouti rats
originating from breeding of a Wistar female rat to a wild rat,(46)
and the congenital scoliosis mouse model (CSmo) developed by
exposing pregnant DBA/1J mice to 600 ppm of carbon
monoxide on day 9 of gestation(47) (Table 1). Thus, the ISR
model has similarities to HVF mice in having kyphosis, that is
associated with segmentation defects affecting mainly the
lumbar area, as well as narrowing of intervertebral spaces,
irregularity of adjacent ends of vertebral bodies, and wedging
and complete bony fusion of adjacent vertebral bodies.(48,49)
However, the ISR model is suggested to have an autosomal
recessive inheritance(50) and although reduced expression of
Hox10 and Hox11 have been reported,(49) a mutation has not yet
been identified. Details of body weight, lean mass, fat mass, and
BMD content were not reported in the ISR model.(48) The CSmo
model has few similarities to the HVF mice other than scoliosis
which may involve the lumbar vertebrae(47); however, the CSmo
model has scoliosis in association with hemivertebrae and bars
Fig. 2. mCT scan and histology analysis of WT littermates and HVF female mice at 12 weeks. mCT scans showing (A) kyphosis, (B) scoliosis, and (C) fused
lumbar vertebrae (L3 to L6) in HVFmice. (D) Histology of lumbar vertebrae stainedwith hematoxylin and eosin, showing irregularities of the ends of the vb
with displacement of intervertebral discs (arrows) and ossification centers (arrowheads) in HVF mice. vb¼ vertebral body; WT¼wild-type.
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that may affect cervical, thoracic, or lumbar vertebrae.(47) Details
of body weight, lean and fat mass, and BMDwere not reported in
the CSmo model.(47) Three other knockout mouse models with
an allelic deletion of genes encoding members of the Notch
signaling pathway have been reported to develop vertebral
defects (Table 1). These mice have a heterozygous loss of the
mesoderm posterior protein 2 (Mesp2þ/ ), hairy and enhancer of
split 7 (Hes7þ/ ), and delta-like 1 (Dll1þ/ ) genes, and all three
mouse models have been reported to develop autosomal
dominantly inherited vertebral defects with low penetrance.(51)
However, the penetrance and severity of these defects, in
embryos with an allelic deletion (ie, Mesp2þ/ , Hes7þ/ , or
Dll1þ/ ), were increased by exposure to hypoxic conditions, and
the resulting defects included missing pedicles and rib
abnormalities.(51) These findings indicate that the Mesp2þ/ ,
Hes7þ/ , and Dll1þ/ mice do not have any similarities to the HVF
mouse model, which develops autosomal dominant kyphosco-
liosis with high penetrance without any requirement for
environmental challenge such as hypoxia. Null mutations of
Tbx6, a key regulator of the Notch signaling pathway, cause
congenital scoliosis in humans and rats.(27,52–54) However, the
vertebral defects may occur in the cervical, thoracic, or lumber
spine, in contrast to Hvf mice, in which the defects occurred only
in L2 to L5 vertebrae. Thus, our results provide a new rodent
model for hereditary lumbar scoliosis. TBX6 is expressed
throughout the developing axial skeleton, with differential
spatial expression patterns at different time-points, as vertebral
segmentation proceeds in a cranial to caudal direction.(55) We
hypothesize that a noncoding mutation is the cause of the Hvf
phenotype, likely through mutation of a promoter region. The
cellular effect of the mutation is therefore likely to be one of
altered regulation of a pathway, either in a time-specific or
space-specific manner, rather than disruption of a whole
pathway, as is the case with TBX6 null mutations. Thus, if
cranial-caudal development of the spine is either terminated at a
different time or delayed, then this may be more likely to induce
Fig. 3. mCT cross-sectional analysis of spinal column from 12-week-old WT littermates and HVF female mice. (A) Cross-section of spinal column showing
fusion of L4 and L5, and abnormalities of the neural spine between L3 and L4 in HVF mice. (B) Cross-section of lumbar vertebrae fromWT littermates and
HVF mice, revealing altered shape of nc, wider ns, and bone formation near tp in HVF mice. WT¼wild-type; nc¼neural canal; ns¼neural spine;
tp¼ transverse process.
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defects in the caudal part of the spine rather than in the cranial
regions or throughout, or if spatial specificity is disrupted, then a
small specific set of vertebrae may be affected. The time-sensitive
nature of vertebral segmentation is demonstrated by Mbtps1
conditional knockout mice, in which Mbtps1 was knocked-out at
embryonic day 8.5 (E8.5) in the caudal regionof the embryo. These
mice developed fusion of the lower lumbar vertebrae, in a similar
pattern to Hvf mice.(56)
Our studies mapped the Hvf locus to a 5-Mb interval on
chromosome 4A3 (Fig. 4) and the syntenic region (23.2 to 28.2
Mb) in humans (94.2 to 98.8 Mb) is on chromosome 6q16.1.
Genetic mapping studies in humans have revealed loci for
scoliosis and/or kyphosis on chromosomes 8, 17p11.2, and
19q13.3, and these do not correspond to the syntenic region to
mouse chromosome 4A3, thereby indicating that further studies
of HVF mice may also identify a gene for kyphoscoliosis in
Fig. 4. Haplotype analysis using chromosome 4 SNPs in mice affected with HVF. The Hvf locus is inherited with C57BL/6 alleles and is located in a 5-Mb
interval between the centromeric SNP rs4138316 and the telomeric microsatellite locus at the 28.2-Mb position. The region contains nine protein coding
genes that were studied for mutations, 24 pseudogenes, two processed transcripts, three large intergenic ncRNAs, five snRNAs, and three miRNAs.
ncRNA¼noncoding RNA; snRNA¼ small nuclear RNA; miRNA¼microRNA.
Table 1. Phenotypic Features of HVF Mice, CSmo, Heterozygous Knockout Mouse Models (Mesp2þ/ , Hes7þ/ , and Dll1þ/ ), ISR, and
CShu.
Rodent models
Human
HVF CSmoa Mesp2þ/–b Hes7þ/–b Dll1þ/–b ISRc CShud
Derivation of mutation ENU CO TKO TKO TKO SN SN
Inheritance Ad Ni Ad (rp) Ad (rp) Ad (rp) Ar ?
Kyphosis þ – – (–) – (–) – (–) þ †
Scoliosis þ þ – (–) – (þ) – (–) – þ
Fusion of vertebrae þ – – (þ) – (þ) – (–) þ þ
Segmentation defects þ – – (þ) þ (þ) þ (þ) þ þ
Wedged vertebrae þ þ – (–) – (–) – (–) þ þ
Hemivertebrae and bars – þ – (–) – (–) – (–) – þ
Narrow intervertebral spaces þ – ? (?) ? (?) ? (?) þ ?
Body weight # ? ? (?) ? (?) ? (?) ? ?
Lean mass # ? ? (?) ? (?) ? (?) ? ?
Fat mass # ? ? (?) ? (?) ? (?) ? ?
BMD N/# N ? (?) ? (?) ? (?) ? ?
CSmo ¼ congenital scoliosis mouse model; ISR ¼ Ishibashi Rat; CShu ¼ human congenital scoliosis-block vertebrae; ENU ¼ N-ethyl-N-nitrosourea
induced model; CO ¼ carbon monoxide induced; TKO ¼ targeted knock-out; SN ¼ spontaneous naturally occurring; Ad ¼ autosomal dominant; (rp) ¼
reduced penetrance; Ni¼ not inherited; Ar¼ autosomal recessive; ?¼ not reported;þ¼ present; –¼ absent; †¼ patients with kyphosis excluded from
study; N ¼ normal; # ¼ reduced; " ¼ increased.
aPreviously reported (Ishibashi(47)).
bPreviously reported (Sparrow and colleagues(51)), penetrance was increased with exposure to hypoxia. Symbols without parentheses denote
phenotype with normoxia; symbols in parentheses denote phenotype with hypoxia.
cPreviously reported (Ishibashi(46) and Moritake and colleagues(48)).
dPreviously reported (McMaster and Ohtsuka(44)).
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humans. Indeed, kyphosis and/or scoliosis are likely to have the
involvement of many different genes as well as representing
common clinical endpoints for a number of diseases that have
different pathogenetic mechanisms,(8,45) such as the CHARGE
syndrome, which is associated with later-onset scoliosis in more
than 60% of patients.(11) The CHARGE syndrome is due to
mutations of the chromodomain-helicase-DNA-binding protein
7 (CHD7) gene(11) and a CHD7 polymorphism (rs4738824,
chromosome 18q12) has been associated with susceptibility
to idiopathic scoliosis in a group of families of European
descent.(15) However, CHD7 gene abnormalities have not been
identified in other studies of scoliosis pedigrees, thereby
indicating the likely involvement of other genes in the etiology
of the idiopathic forms of kyphosis and/or scoliosis.
Analysis of the genes within the Hvf candidate interval
(Supporting Table 1) did not reveal any links with molecular
pathways known to be involved with kyphosis, patterning
defects, or vertebral fusion, such as the Notch pathway.
However, the candidate interval contains Ndufaf4, which
encodes a protein that is required for assembly of complex I
of the mitochondrial respiratory chain, and affected individuals
from a family with isolated mitochondrial complex I deficiency
due to homozygous mutations in NDUFAF4 have been reported
to have kyphosis; however, this occurred in conjunction with
severe metabolic acidosis, encephalopathy, and death in
infancy, whereas heterozygous parents and siblings were
unaffected.(57) HVF mice did not have premature death or
encephalopathy; moreover, the HVF phenotype was inherited in
an autosomal dominant manner, thereby indicating that HVF is
unlikely due to defects of Ndufaf4. Furthermore, mice with a
heterozygous deletion of Ndufs4, that encodes one of the
proteins within complex I, and therefore has isolated complex I
deficiency, were indistinguishable from WT mice, with no
kyphoscoliosis reported.(58) The candidate interval also contains
threemicroRNAs; however, these are all novel microRNAs whose
targets are unknown.
We also investigated Map3k7, a coding variant (Ala179Asp)
that was located outside the critical interval, because Map3k7
(also known as TGF-b-activated kinase 1 [TAK1]) is a member of
the signaling pathway that links TGF-b and bone morphoge-
netic protein (BMP) with activation of the p38 MAPK pathway,
which plays a critical role in bone growth. However this Map3k7
variant did not cosegregate with the HVF phenotype, and
involvement of this missense Map3k7 variant in causing HVF is
unlikely, and consistent with other observations from mutant
mouse and human disease studies. Thus, homozygous Map3k7
knockout mice are embryonically lethal, and heterozygous
Map3k7 knockout mice have no phenotype.(59,60) Moreover,
osteoblast-specific Map3k7 knockout mice developed clavicular
hypoplasia and delayed closure of the fontanelles, similar to the
human disorder of cleidocranial dysplasia, reduced trabecular
bone, and a moderate decrease in body weight, but did not
develop vertebral defects.(61) Conversely, osteoclast precursor-
specific Map3k7 knockout mice displayed skull overgrowth and
increased trabecular bone, but again did not develop any
vertebral abnormalities.(62,63) Furthermore, heterozygous muta-
tions in MAP3K7 in humans cause the syndromic skeletal
disorders of cardiospondylocarpofacial syndrome and fronto-
metaphyseal dysplasia.(64,65) These studies illustrate that
Map3k7 plays an important role in bone development, and it
is possible that the HVF mice harbor a noncoding mutation
within the critical interval that alters the regulation of Map3k7
specifically in developing vertebrae. Indeed, a recent study has
suggested that familial idiopathic kyphoscoliosis/scoliosis in a
series of seven families, in whom a critical interval of 3.5 Mb on
chromosome 5p was previously defined, may be due to a
noncodingmutationwithin a regulatory region that affected the
expression of an unknown target gene(s).(66) Because there are
no known links between any of the genes within the Hvf
candidate interval and pathways involved with kyphosis,
patterning defects, or vertebral fusion, the genetic defect
causing the HVF phenotype may reveal novel biological
mechanisms involved with these processes.
In humans, a number of inherited diseases, with autosomal
dominant and recessive, and X-linked inheritances, have been
described to be due to noncoding mutations. These include
triphalangeal thumb/preaxial polydactyly (autosomal dominant
with variable penetrance), due to mutations in the ZPA
regulatory sequence, a long-range cis-acting regulator of Sonic
Hedgehog (SHH) gene expression(67–69); and autosomal recessive
isolated pancreatic agenesis due to noncoding mutations
downstream of pancreas-specific transcription factor 1a
(PTF1A).(70) Such mutations are frequently large deletions or
duplications, but may also consist of single-nucleotide muta-
tions, similar to those most frequently induced by ENU, as found
in isolated pancreatic agenesis, and recently described in the
promoter region of ovo-like zinc finger 2 (OVOL2) in families with
autosomal-dominant corneal endothelial dystrophies.(71) Muta-
tions upstream of PTF1Awere found to reduce the expression of
PTF1A, whereas mutations in the OVOL2 promoter were able to
induce OVOL2 expression, likely leading to aberrant ectopic
OVOL2 expression in the developing cornea.(70,71) Either of these
two molecular mechanisms could account for the dominant
disease presentation in Hvf mice, eg, through a dosage effect
due to a reduction in the level of a critical transcript, or through
ectopic induction of a transcript, and either of thesemay be time
and/or spatially specific. Future work to identify the Hvf
causative mutation will focus on analyses of the six intergenic
and three intronic noncoding variants in transcriptional assays,
such as luciferase assays, similarly to those undertaken for PTF1A
and OVOL2-associated noncoding variants.(70,71) To determine
the specific role of the variants in somitogenesis, these assays
may need to be undertaken in a somite cell-line, such as cells
derived from pluripotent stem cells,(72) or in bone-specific cells
such as chondrocytes.
In summary, our study has established an ENU-induced
mouse model for autosomal-dominant congenital scoliosis and
identification of the causative genetic defect will help in further
elucidating the molecular mechanisms associated with congen-
ital scoliosis due to segmentation defects.
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